First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Executive summary-Reference-Cited by-同舟云学术

First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Executive summary

Published:2016-01 Issue:1 Volume:23 Page:3-13
ISSN:0908-665X
Container-title:Xenotransplantation
language:en
Short-container-title:Xenotransplantation

Author:

Hering Bernhard J.¹,Cozzi Emanuele²³,Spizzo Thomas⁴,Cowan Peter J.⁵,Rayat Gina R.⁶,Cooper David K.C.⁷,Denner Joachim⁸

Affiliation:

1. Schulze Diabetes Institute; Department of Surgery; University of Minnesota; Minneapolis MN USA

2. Transplant Immunology Unit; Department of Transfusion Medicine; Padua University Hospital; Padua Italy

3. CORIT (Consortium for Research in Organ Transplantation); Padua Italy

4. Spring Point Project; Minneapolis MN USA

5. Immunology Research Centre; St Vincent's Hospital; Melbourne Vic. Australia

6. The Surgical-Medical Research Institute; Alberta Diabetes Institute; University of Alberta; Edmonton AB Canada

7. Thomas E. Starzl Transplantation Institute; Pittsburgh PA USA

8. Robert Koch Institute; Berlin Germany

Publisher

Wiley

Subject

Transplantation,Immunology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/xen.12231/fullpdf

Reference49 articles.

1. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes- executive summary;Hering;Xenotransplantation,2009

2. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 1: key ethical requirements and progress toward the definition of an international regulatory framework;Cozzi;Xenotransplantation,2009

3. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 2: source pigs;Schuurman;Xenotransplantation,2009

4. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 3: pig islet product manufacturing and release testing;Korbutt;Xenotransplantation,2009

5. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial;Cooper;Xenotransplantation,2009

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infection and clinical xenotransplantation: Guidance from the Infectious Disease Community of Practice of the American Society of Transplantation;American Journal of Transplantation;2023-03

2. Regulatory Considerations and Oversight: A Japanese Perspective;Xenotransplantation;2023

3. Yield, cell composition, and function of islets isolated from different ages of neonatal pigs;Frontiers in Endocrinology;2022-12-21

4. Risks of Infectious Disease in Xenotransplantation;New England Journal of Medicine;2022-12-15

5. Xenotransplantation of pig islet cells: Potential adverse impact of virus infections on their functionality and insulin production;Xenotransplantation;2022-12-10